NSC |
Compound |
Enrichment |
Correlation |
NSC 645892 |
Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- |
0.0162638908166157 |
0.08564473 |
NSC 648365 |
Insulin-Methotrexate conjugate |
0.0162638908166157 |
0.031145905 |
NSC 658370 |
Null |
0.0162638908166157 |
-0.15713776 |
NSC 658455 |
(S,S)(-)3,5-Dimethoxy N-(.alpha.-Phenethyl)phenyl isopropylamine |
0.0162638908166157 |
-0.08840247 |
NSC 662253 |
Null |
0.0162638908166157 |
-0.23218945 |
NSC 663337 |
Null |
0.0162638908166157 |
-0.29325486 |
NSC 669167 |
4-azido-2-chloro-3-cyanoquinoline |
0.0162638908166157 |
-0.18785778 |
NSC 670230 |
4,5-Dimethyl-11H-pyrido[4,3-a]carbazole |
0.0162638908166157 |
-0.31553921 |
NSC 68091 |
WLN: WS3&1U1SW3 -T |
0.0162638908166157 |
-0.27397054 |
NSC 683332 |
Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer |
0.0162638908166157 |
-0.24554719 |